Given the rally in the S&P 500 and the Nasdaq over the last year, it may be wise to consider stocks that should be less volatile during market corrections. Even better is when stocks have dividend yields over 5%. Here are a few stocks to consider.

Organon & Co. sells its products to drug wholesalers, retailers, hospitals, pharmacies, clinics, government agencies, and other institutions worldwide.

These 3 undervalued healthcare stocks in 2023 are attractive today for their attractive valuations and total return potential.

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions.

Here's a look at two drug makers that we recommend in our Growth & Income Portfolio. The stocks in this portfolio are generally higher-quality, larger-cap companies that have fallen out of favor.